Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Deferred Taxes (2018 - 2021)

Historic Deferred Taxes for Dna X (SONM) over the last 4 years, with Q4 2021 value amounting to -$26000.0.

  • Dna X's Deferred Taxes fell 21818.18% to -$26000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$35000.0, marking a year-over-year decrease of 26666.67%. This contributed to the annual value of -$35000.0 for FY2021, which is 26666.67% down from last year.
  • According to the latest figures from Q4 2021, Dna X's Deferred Taxes is -$26000.0, which was down 21818.18% from -$4000.0 recorded in Q3 2021.
  • In the past 5 years, Dna X's Deferred Taxes registered a high of $244000.0 during Q4 2018, and its lowest value of -$91000.0 during Q3 2018.
  • In the last 4 years, Dna X's Deferred Taxes had a median value of -$3000.0 in 2021 and averaged $15933.3.
  • Over the last 5 years, Dna X's Deferred Taxes had its largest YoY gain of 58181.82% in 2020, and its largest YoY loss of 87500.0% in 2020.
  • Quarter analysis of 4 years shows Dna X's Deferred Taxes stood at $244000.0 in 2018, then plummeted by 52.46% to $116000.0 in 2019, then tumbled by 81.03% to $22000.0 in 2020, then tumbled by 218.18% to -$26000.0 in 2021.
  • Its last three reported values are -$26000.0 in Q4 2021, -$4000.0 for Q3 2021, and -$2000.0 during Q2 2021.